The chief of the med-tech firm says the market has not grown as expected but will expand exponentially over the next five years.
There are too many Indian PE funds without enough track record, he says.
Budget would need to provide clarity about the prospective nature of taxation, she says.
The finance head of the drugmaker says inorganic growth in the past now contributes a quarter of revenue.
The venture investment arm of Cipla has backed US-based Chase Pharma, Manipal Group-promoted Stempeutics Research besides two biotech companies.
The company expects its small molecule API and ANDA business to be lead revenue generator followed by research services and branded formulations.
The MFI plans to appoint a consultancy firm to help it set up banking operations.
The online travel agency, which has raised $120 million in funding to date, derives one-fifth of its traffic from mobile.
TVM Capital has committed $100 million investment in the UK-based parent of the IVF treatment chain.
The head of the beauty services and products company says going forward the products unit will generate 25 per cent of revenue against 20 per cent now.
The founder and CEO of the PE firm says the deal with India Infoline took a long time to seal, which affected new investments.
Mitra says Flipkart is more like Amazon while Myntra is like ASOS.
Sinha claims IDFC Alternatives has been the only fund that has consistently distributed capital right from year one.
The global network of PE firms has recently added India to its investment strategy for emerging markets.
The promoters’ holding arm recently raised funding from KKR.
The MD and co-head of Investment Management Asia at the private asset management firm says 80% of local PE fund managers are dead or inactive.
The chief of the north-based realtor says land prices will increase with the new land acquisition policy which will affect supply of affordable housing.
A flexible investment strategy is a good way to invest in India if you have a team of GPs that has the track record and will to do it, according to Chadha.
The group, which secured $100 million from Olympus Capital in 2011, is looking to go for an IPO either in London or Mumbai.
Vasudevan says he prefers investing in Southeast Asia as valuations are less stretched in the region.